Description:

GOG-0218 Common Toxicity Reporting Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F1B8AE82-9F7E-1D11-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F1B8AE82-9F7E-1D11-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Fallopian Tube Cancer NCT00262847 Toxicity - GOG-0218 Common Toxicity Reporting Form - 2305920v3.0

No Instruction available.

  1. StudyEvent: GOG-0218 Common Toxicity Reporting Form
    1. No Instruction available.
Header Module
Adverse Events - Section 1
Has the patient received any transfusions during this course of therapy?
Was patient hospitalized as a result of reported adverse events?
Were cytokines administered this course?
Has an Adverse Drug Reaction Report been filed?
Adverse Events - Section 2
Peripheral WBC count done?
1000/uL
Peripheral Granulocytes count done? (ANC/)
1000/uL
Peripheral Platelet count done?
1000/uL
Hemoglobin done?
g/dL
CTC Adverse Event Attribution Code
CTC Adverse Event Attribution Code
CTC Adverse Event Attribution Code
CTC Adverse Event Attribution Code
Adverse Events - Section 3
CTC Adverse Event Term
The CTCAE data entered above is
CTC Adverse Event Attribution Code
Comments
Footer Module

Similar models